AstraZeneca to increase investment in Virginia manufacturing facility to $4.5 billion
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030
The NDA submission follows the successful completion of a pivotal Phase III global clinical trial
Takeda will seek an external partner to leverage its cell therapy platform technologies
Proposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
India currently hosts more than 10,075 biotech startups
Subscribe To Our Newsletter & Stay Updated